Company Filing History:
Years Active: 2008-2010
Title: Innovations of Javier Carrasco in Cancer Research
Introduction
Javier Carrasco is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his innovative work on antigenic peptides.
Latest Patents
Javier Carrasco holds two patents related to MAGE-C2 antigenic peptides. His inventions focus on isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2, and expression vectors comprising these nucleic acid molecules. Additionally, his patents include host cells transformed or transfected with the nucleic acid molecules or expression vectors, as well as tetramers that comprise the peptides, HLA molecules, β-microglobulin, and binding partners. These inventions also encompass methods for utilizing the peptides, nucleic acid molecules, expression vectors, and complexes, along with cytolytic T cells that recognize the peptides in complex with an HLA molecule.
Career Highlights
Javier Carrasco is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research and innovations. His work has the potential to impact cancer treatment significantly.
Collaborations
Some of his notable coworkers include Aline Van Pel and Daniele Godelaine, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Javier Carrasco's contributions to cancer research through his patents on MAGE-C2 antigenic peptides highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in cancer therapies.